The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
The mechanism of action of radiosensitization of conventional chemotherapeutic agents
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Salonga, D. S., Danenberg, K. D., Johnson, M. R., Metzger, R., Groshen, S. G., Tsao-Wei, D. D., Lenz, H.-J., Leichman, C. G., Leichman, L., Diasio, R. B., et al. (2000) · PubMed · Cited by 829
A phase I clinical, plasma, and cellular pharmacology study of gemcitabine.
Abbruzzese, J. L., Grunewald, R., Weeks, E. A., Gravel, D., Adams, T., Nowak, B., Mineishi, S., Tarassoff, P., Satterlee, W., & Raber, M. N. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.3.491 · Cited by 759
Oxaliplatin: A review of preclinical and clinical studies
Raymond, E., Chaney, S. G., Taamma, A., & Cvitkovic, E. (1998) · Annals of Oncology · doi:10.1023/a:1008213732429 · Cited by 643
Rixe, O., Ortuzar, W., Alvarez, M., Parker, R., Reed, E., Paull, K., & Fojo, T. (1996) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)81490-6 · Cited by 615
Shirota, Y., Stoehlmacher, J., Brabender, J., Xiong, Y.-P., Uetake, H., Danenberg, K. D., Groshen, S., Tsao-Wei, D. D., Danenberg, P. V., & Lenz, H.-J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.23.4298 · Cited by 610
Oxaliplatin: mechanism of action and antineoplastic activity.
Raymond, É., Faivre, S. J., WOYNAROWSKI, J. M., & Chaney, S. G. (1998) · PubMed · Cited by 520
Sawada, N., Ishikawa, T., Sekiguchi, F., Tanaka, Y., & Ishitsuka, H. (1999) · PubMed · Cited by 319
Radiosensitization of pancreatic cancer cells by 2′,2′-difluoro-2′-deoxycytidine
Lawrence, T. S., Chang, E. Y., Hahn, T. M., Hertel, L. W., & Shewach, D. S. (1996) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)02134-5 · Cited by 308
Self-citationGrunewald, R., Abbruzzese, J. L., Tarassoff, P., & Plunkett, W. (1991) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00685109 · Cited by 244
Shewach, D. S., Hahn, T. M., Chang, E., Hertel, L. W., & Lawrence, T. S. (1994) · PubMed · Cited by 228
Self-citationPendyala, L., & Creaven, P. J. (1993) · PubMed · Cited by 209
Mathé, G., Kidani, Y., Segiguchi, M., Eriguchi, M., Fredj, G., Peytavin, G., Misset, J. L., Brienza, S., de Vassals, F., Chenu, E., et al. (1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90003-6 · Cited by 187
Wazer, D. E., Liu, X. L., Chu, Q., Gao, Q., & Band, V (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.9.3687 · Cited by 185
Mamenta, E. L., Poma, E., Kaufmann, W. K., Delmastro, D. A., Grady, H. L., & Chaney, S. G. (1994) · PubMed · Cited by 181
Tashiro, T., Kawada, Y., Sakurai, Y., & Kidani, Y. (1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90004-8 · Cited by 171
McGinn, C. J., Shewach, D. S., & Lawrence, T. S. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.17.1193 · Cited by 165
Self-citationEnhancement of tumor radioresponse in vivo by gemcitabine.
Milas, L., Fujii, T., Hunter, N. R., Elshaikh, M. A., Mason, K. A., Plunkett, W. K., Ang, K. K., & Hittelman, W. N. (1999) · PubMed · Cited by 162
Eisbruch, A., Shewach, D. S., Bradford, C. R., Littles, J. F., Teknos, T. N., Chepeha, D. B., Marentette, L. J., Terrell, J. E., Hogikyan, N. D., Dawson, L. A., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.3.792 · Cited by 145
Self-citationEffect of the diaminocyclohexane carrier ligand on platinum adduct formation, repair, and lethality
Page, J. D., Husain, I., Sancar, A., & Chaney, S. G. (1990) · Biochemistry · doi:10.1021/bi00456a026 · Cited by 139
Scheeff, E. D., Briggs, J. M., & Howell, S. B. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.3.633 · Cited by 137
Platinum complexes as radiosensitizers of hypoxic mammalian cells.
Douple, E. B., & Richmond, R. C. (1978) · Europe PMC (PubMed Central) · Cited by 134
Effect of cis-dichlorodiammine platinum IIand X rays on mammalian cell survival
Carde, P. P., & Laval, F. (1981) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(81)90011-0 · Cited by 134
Chemoradiotherapy for cervical cancer
Rose, P. G. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00352-5 · Cited by 131
Maximizing therapeutic gain with gemcitabine and fractionated radiation
Mason, K. A., Milas, L., Hunter, N. R., Elshaikh, M. A., Buchmiller, L., Kishi, K., Hittelman, K. W., & Ang, K. K. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00134-0 · Cited by 103
Freyer, G., Bossard, N., Romestaing, P., Mornex, F., Chapet, O., Trillet-Lenoir, V. N., & Gérard, J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.9.2433 · Cited by 102
Radiosensitization by oxaliplatin in a mouse adenocarcinoma: influence of treatment schedule
Cividalli, A., Ceciarelli, F., Livdi, E., Altavista, P., Cruciani, G., Marchetti, P., & Danesi, D. T. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)02792-4 · Cited by 101
The role of apoptosis in 2',2'-difluoro-2'-deoxycytidine (gemcitabine)-mediated radiosensitization.
Lawrence, T. S., Davis, M. A., Hough, A., et al. (2001) · PubMed · Cited by 90
Self-citationDunn, T. A., Schmoll, H., Grünwald, V., Bokemeyer, V., & Casper, J. (1997) · Investigational New Drugs · doi:10.1023/a:1005800520747 · Cited by 88
The novel trinuclear platinum complex BBR3464 induces a cellular response different from cisplatin
Servidei, T., Ferlini, C., Riccardi, A., Meco, D., Scambia, G., Segni, G., Manzotti, C., & Riccardi, R. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00061-2 · Cited by 86
Fields, M. T., Eisbruch, A., Normolle, D. P., Orfali, A., Davis, M. A., Pu, A. T., & Lawrence, T. S. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00447-8 · Cited by 80
Self-citationFluoropyrimidine-radiation interactions in cells and tumors
Lawrence, T. S., Tepper, J. E., & Blackstock, A. W. (1997) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(97)80024-0 · Cited by 61
Self-citationBlackstock, A. W., Hess, S., Chaney, S. G., & Tepper, J. E. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)90220-1 · Cited by 46
Self-citationStratford, I. J., Williamson, C. J., & Adams, G. E. (1980) · British Journal of Cancer · doi:10.1038/bjc.1980.93 · Cited by 44
Combined chemotherapy and radiation in locally advanced nonsmall-cell lung cancer
Jassem, J. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(00)00387-9 · Cited by 43
Richmond, R. C. (1984) · Radiation Research · doi:10.2307/3576334 · Cited by 41
Jurgenliemk-Schulz, I. M., Renes, I. B., Rutgers, D. H., Everse, L. A., Bernsen, M. R., Otter, W. D., & Battermann, J. J. (1997) · Radiation Oncology Investigations · doi:10.1002/(sici)1520-6823(1997)5:2<43::aid-roi1>3.0.co;2-j · Cited by 27
(1996) · PubMed
Cited by
Role of cell cycle in mediating sensitivity to radiotherapy
Pawlik, T. M., & Keyomarsi, K. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.03.005 · Cited by 1,102
Therapeutic targeting of the hypoxic tumour microenvironment
Singleton, D. C., Macann, A., & Wilson, W. R. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00539-4 · Cited by 484
The concurrent chemoradiation paradigm—general principles
Seiwert, T. Y., Salama, J. K., & Vokes, E. E. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0714 · Cited by 443
Wang, Y., Deng, W., Li, N., Neri, S., Sharma, A., Jiang, W., & Lin, S. H. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00185 · Cited by 374
Abrams, R. A., Winter, K. A., Regine, W. F., Safran, H., Hoffman, J. P., Lustig, R., Konski, A. A., Benson, A. B., Macdonald, J. S., Rich, T. A., et al. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.11.039 · Cited by 278
Metadata
- Authors
- Lawrence, T. S., Blackstock, A. W., & McGinn, C.
- Venue
- Seminars in Radiation Oncology
- Publisher
- Elsevier BV
- Published
- 2003-01
- Volume
- 13
- Issue
- 1
- Pages
- 13-21
- ISSN
- 1053-4296 (ISSN-L)
- OpenAlex
- W1966675362
- Cited by
- 296
- References
- 37
- FWCI
- 12.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.